Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Apogee execs join Paragon to scale its R&D, company creation engine

Some people would think about taking a break for several quarters after selling a biotech for $10.9 billion. Michael Henderson and five of his fellow executives from Apogee Therapeutics are not fading ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 13 October →